The OTC Trading Strategy in India: A Real Guide for Unlisted Shares & Derivatives

Forget the textbook definition. In India, OTC (Over-the-Counter) trading means you're dealing directly with another party, not through the centralized order book of the NSE or BSE. There's no live ticker, no public bid-ask spread for everyone to see. It's a negotiated market.

Primarily, it involves two things: unlisted shares (companies not yet on the stock exchange) and certain OTC derivatives (like some forex and interest rate contracts). The big draw is unlisted shares. You're trying to get into a company like Tata Capital or a hot startup before its IPO, hoping to cash out when it lists at a premium.

Here's the first reality check: calling it a 'strategy' is generous. It's often more like speculative private placement with terrible exit options. Your position size calculator becomes your best friend here, because you can't just hit 'sell' when you're wrong. You have to find another buyer, and that buyer will want a discount.

This is where most guides gloss over the details. The costs in OTC trading, especially for unlisted shares, aren't as transparent as a ₹20 brokerage charge on Zerodha.

The Spread is Everything

Brokers and dealers don't charge you a flat fee. They make money on the spread – the difference between what they buy the share for and what they sell it to you for. If they acquired shares from an employee at ₹1,000, they might quote you ₹1,200. That ₹200 spread is their profit, baked right into your entry price. You're already 20% in the hole before the trade even starts.

Official Costs

• Stamp Duty: Around 0.015% of the trade value. Small, but it adds up.
• DP Charges: Your Depository Participant will charge for crediting shares to your Demat.
• Platform Fees: Some digital platforms have listing or transaction fees.

The Minimum Investment Trap

They'll tell you you can start with ₹10,000. Technically true on some apps. But the serious plays? Forget it. For a decent shot at a known pre-IPO company, you're looking at ₹5 to ₹10 lakhs minimum per deal. This isn't for dabbling. I once put ₹7 lakh into a fintech company's unlisted shares. The liquidity was so poor it took me 4 months to offload half my position, and I had to drop my asking price by 15% to do it.

Tax Headache

Hold unlisted shares for less than 24 months? Gains are added to your income and taxed at your slab rate (could be 30%+). Hold for more than 24 months? It's a Long-Term Capital Gain taxed at 20% with indexation benefit. Keep careful records. The spread definition in OTC isn't just a cost; it directly alters your cost basis for tax calculation.

You won't find OTC unlisted shares on your Upstox or Angel One app. You need specialized intermediaries. Here’s a breakdown of the landscape.

My experience? I've used a mix. For a large block in a manufacturing company, I went through a traditional broker (cost: a 12% spread). For a smaller, speculative punt on a edtech startup, I used a digital platform (cost: 18% spread plus a 0.5% platform fee). The digital process was smoother, but the spread killed the potential return.

Remember, these entities are facilitators. They are not guaranteeing returns or providing liquidity. Their job is to match buyers and sellers, for a price.

Okay, let's talk strategy. This isn't about drawing lines on a chart. A functional OTC trading strategy in India is 70% due diligence, 20% patience, and 10% execution.

1. The Pre-IPO Play (The Most Common)

The Idea: Buy shares of a company that has publicly filed its Draft Red Herring Prospectus (DRHP) with SEBI. The IPO is coming in 6-12 months. The Reality: This is crowded. Everyone knows about it. The price is already inflated. Your edge comes from analyzing the IPO grey market premium (GMP) trends and the company's fundamentals versus its listed peers. I bought into a logistics company post-DRHP. The IPO got delayed twice, the GMP evaporated, and I sold at breakeven after 14 months. A wasted opportunity.

2. The Long-Term Venture Bet

The Idea: Identify a growing, profitable unlisted company years before any IPO talk. Think of it as angel investing without the board seat. The Reality: This requires deep sector knowledge and access to financials (which good brokers should provide). You're looking for consistent revenue growth, clean governance, and a clear path to listing. This is a swing trading mindset but on a 3-5 year timeframe. Your exit is either a strategic sale to another investor or the eventual IPO.

3. The Liquidity Arbitrage (For the Connected)

The Idea: This is advanced. You use your network to buy shares from distressed sellers (e.g., employees needing cash) at a steep discount to the prevailing OTC market price, then sell at the market price. The Reality: This is less a strategy and more a business. It requires capital, a strong network, and the ability to hold inventory. The spread here is your profit.

Your strategy must include a clear exit plan. Ask yourself: "Do I sell 50% at IPO listing? Do I hold for 6 months post-listing? What if the IPO is cancelled?" If you don't have answers, you're gambling.

Volatility in Nifty is not your risk model here. These are the real dangers.

1. Extreme Illiquidity: This is the king of all risks. There are no market makers. You cannot exit during a market panic. I learned this the hard way in 2022. A company I held faced a negative news report. In a listed stock, I'd be out in seconds with a 5% loss. In the OTC market, my broker simply said, "No buyers at any price right now." I watched my paper loss deepen for weeks with zero recourse. It was a brutal lesson in the true meaning of a margin call scenario, but without the use.

2. Valuation Black Box: How is the price of ₹1,250 per share determined? Often, it's just what the last few private transactions were at, or a multiple the broker pulls based on vague comparables. There is no daily mark-to-market. You are trusting the broker's quote.

3. Counterparty & Fraud Risk: Are you sure the person selling you the shares actually owns them? Is the transfer done properly via Demat? Fraud in private share transfers, while less common now with Demat, still exists. Deal only with registered intermediaries.

4. Regulatory & Corporate Action Risk: The company could change its IPO plans. SEBI could reject its filing. A new tax rule could impact demand (like the Finance Act 2023 reporting rules for transactions over ₹20L). You have zero control.

5. Information Asymmetry: Promoters, large investors, and employees know more than you. Always. Assume you are at the bottom of the information food chain.

While unlisted shares get the hype, OTC derivatives are the institutional game. Governed by the RBI, these are contracts like forward rate agreements, currency swaps, or exotic options tailored between two parties (often banks and corporates).

Why should you care? Because recent changes affect accessibility. In 2024/25, the RBI liberalized the FX OTC derivatives market. Now, even retail users can access non-deliverable derivative contracts (NDDCs) involving INR for hedging purposes. Previously, this was mostly for large corporates.

The Strategic Angle: For an individual trader, the main link is understanding that large OTC derivative markets exist and can influence the underlying assets you might trade on exchange. A company hedging its forex exposure in the OTC market can impact its profitability, which can affect its stock price (listed or unlisted).

The big regulatory push is transparency. The RBI's 2026 mandate for a Unique Transaction Identifier (UTI) for every OTC derivative trade shows they're watching this space closely. As a strategy, direct retail participation is complex and capital-intensive, but being aware of its existence makes you a more informed trader overall.

Let's make it concrete. Here's how a typical unlisted share trade goes down.

1. Research & Selection: You identify a company (e.g., 'XYZ Fintech') through broker research or platform listings.
2. Broker/Platform Engagement: You contact a registered broker (e.g., from the list in section 3) and express interest.
3. Due Diligence Package: The broker should provide you with financials, a valuation note, and details of the seller (often anonymized). If they don't, walk away.
4. Price Negotiation: You get a quote, say ₹1,800 per share. There is little room to negotiate. You ask about the spread - how much lower they bought it for. They likely won't tell you precisely.
5. Terms Agreement: You agree on price and quantity. You sign a terms sheet or agreement.
6. Funds & KYC: You transfer funds to the broker's designated escrow or client account. Your full KYC (PAN, Aadhaar, Demat details) is completed.
7. Demat Transfer: Upon receipt of funds, the broker initiates an off-market transfer of shares from the seller's Demat to yours. You receive a confirmation from your DP.
8. Post-Trade: You now hold an illiquid asset. You monitor company news, IPO rumours, and stay in touch with your broker for exit opportunities.

The entire process can take 3-10 days. It feels archaic compared to clicking a button on Exness or IC Markets for forex, but that's the nature of a bilateral, off-exchange deal.

Here's my blunt take after years in this space.

For 95% of traders, the answer is NO. Your time, capital, and energy are better spent mastering a liquid market. The lack of control, high costs, and illiquidity are massive handicaps. It's not trading; it's illiquid private investing with extra steps.

Who might consider it?

• High Net-Worth Individuals (HNIs) who can allocate 5-10% of their portfolio to high-risk, illiquid assets and not lose sleep.
• Professionals with insider sector knowledge (e.g., a pharma expert buying unlisted pharma shares).
• Extremely patient capital with a 3-7 year horizon.

If you proceed, treat it as a satellite portfolio allocation. Never trade OTC with money you might need. Never chase rumours. Your first goal is capital preservation, not moonshots. Start with a small amount via a reputable platform to understand the process before scaling up.

An OTC trading strategy isn't about clever entries and exits. It's about sourcing, due diligence, and managing illiquidity. If that doesn't sound exciting, stick to the charts on the NSE. There's plenty of money to be made - and lost - there, with the luxury of being able to get out when you want.